SLC5A2 and Decreased total neutrophil count: It has also recently been reported that empagliflozin, an inhibitor of the renal glucose cotransporter sodium glucose cotransporter 2 (SGLT2) which is an anti-diabetic drug, could be considered as an alternative therapy for neutropenia cases.